The Munich-LTX-Score: Predictor for survival after lung transplantation

Clinical Transplantation

Volumn 26, Issue 1, 2012, Pages 173-183

  Huppmann, Patrick ^a   Neurohr, Claus ^a   Leuschner, Stefan ^a   Leuchte, Hanno ^a   Baumgartner, Rainer ^a   Zimmermann, Gregor ^a   Meis, Tobias ^a   von Wulffen, Werner ^a   Überfuhr, Peter ^a   Hatz, Rudolf ^a   Frey, Lorenz ^b   Behr, Jürgen ^a,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

BOS; Lung transplantation; Predictor; Score; Survival

Indexed keywords

HLA DR ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS;

ACUTE GRAFT REJECTION; ADULT; ARTICLE; BRONCHIOLITIS OBLITERANS; DONOR; FEMALE; GRAFT RECIPIENT; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUNICH LUNG TRANSPLANTATION SCORE; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE;

ADOLESCENT; ADULT; BRONCHIOLITIS OBLITERANS; CHILD; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; YOUNG ADULT;

EID: 84856636234     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2011.01573.x     Document Type: Article

References (63)

1. Martinu T, Cheng DF, Palmer SM. Acute rejection and humoral sensitization in lung transplant recipients. Proc Am Thorac Soc 2009: 6: 54.
2. Christie JD, Edwards LB, Aurora P et al. Registry of the International Society for Heart and Lung Transplantation: twenty-sixth official adult lung and heart/lung transplantation report-2009. J Heart Lung Transplant 2009: 28: 1031.
3. Cooper JD, Billingham M, Egan T et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. The International Society for Heart and Lung Transplantation. J Heart Lung Transplant 1993: 12: 713.
4. Stewart S, Fishbein MC, Snell GI et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007: 26: 1229.
5. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002: 21: 297.
6. Sharples LD, McNeil K, Stewart S, Wallwork S. Risk factors for bronchiolitis obliterans syndrome: a systematic review of recent publications. J Heart Lung Transplant 2002: 21: 271.
7. Bhorade SM, Stern E. Immunosuppression for lung transplantation. Proc Am Thorac Soc 2009: 6: 47.
8. Burton CM, Iversen M, Scheike T, Carlsen J, Andersen CB. Is lymphocytic bronchitis a marker of acute rejection? An analysis of 2697 transbronchial biopsies after lung transplantation. J Heart Lung Transplant 2008: 27: 1128.
9. Glanville AR, Aboyoun CL, Havryk A et al. Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation. Am J Respir Crit Care Med 2008: 177: 1033.
10. Hadjiliadis D, Duane DR, Steele MP et al. Gastroesophageal reflux disease in lung transplant recipients. Clin Transplant 2003: 17: 363.
11. Hopkins PM, Aboyoun CL, Chhajed PN et al. Association of minimal acute rejection in lung transplant patients with obliterative bronchiolitis. Am J Respir Crit Care Med 2004: 170: 1022.
12. Khalifah AP, Hachem RR, Charkinala MM et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 2004: 170: 181.
13. Neurohr C, Huppmann P, Leuchte H et al. Human herpes virus 6 in bronchoalveolar lavage fluid after lung transplantation: a risk factor for bronchiolitis obliterans syndrome? Am J Transplant 2005: 5: 2982.
14. Neurohr C, Huppmann P, Zimmermann G et al. Tacrolimus and mycophenolate mofetil as first line immunosuppression after lung transplantation. Transplant Int 2009: 22: 635.
15. Belperio JA, Weigt SS, Fishbein MC, Lynch JP. Chronic lung allograft rejection - mechanisms and therapy. Proc Am Thorac Soc 2009: 6: 108.
16. Verleeden GM, Dupont LJ. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2004: 77: 1465.
17. Yates B, Murphy DM, Forest IA et al. Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 2005: 172: 772.
18. Egan TM, Murray S, Bustami RT et al. Development of the new lung allocation system in the United States. Am J Transplant 2006: 6: 1212.
19. Russo MJ, Davies RR, Hong KN et al. Who is the high-risk recipient? Predicting mortality after lung transplantation using pretransplant factors. J Thorac Cardiovasc Surg 2009: 138: 1234.
20. Haldorson JB, Bakthavatsalam R, Fix O, Reyers JD, Perkins JD. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant 2008: 8: 1.
21. Rana A, Hardy MA, Halazun KJ et al. Survival following liver transplantation (SOFT) Score: a novel method to predict patient survival following liver transplantation. Am J Transplant 2008: 8: 2537.
22. Neurohr C, Huppmann P, Samweber B et al. Prognostic value of bronchoalveolar lavage neutrophilia in stable lung transplant recipients. J Heart Lung Transplant 2009: 28: 468.
23. Neurohr C, Huppmann P, Thum D et al. Potential functional and survival benefit of double over single lung transplantation for selected patients with idiopathic pulmonary fibrosis. Transpl Int 2010: 23: 887.
24. Yousem SA, Berry GJ, Cagle PT et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J Heart Lung Transplant 1996: 15: 1.
25. Mash SG, Albert ED, Bodmer WF et al. Nomenclature for factors for the HLA system, 2002. Tissue Antigens 2002: 60: 407.
26. Burton CM, Milman N, Carlsen J et al. The Copenhagen National Lung Transplant Group: survival after single lung, double lung and heart lung transplantation. J Heart Lung Transplant 2005: 24: 1834.
27. De Perrot M, Chaparro C, McRae K et al. Twenty year experience of lung transplantation at a single centre: influence of recipient diagnosis on long-term survival. J Thorac Cardiovasc Surg 2004: 127: 1493.
28. Moffat SD, Demers P, Robbins RC et al. Lung transplantation: a decade of experience. J Heart Lung Transplant 2005: 24: 145.
29. Burton CM, Carlsen J, Mortensen J, Andersen CB, Milman N, Iversen M. Long term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. J Heart Lung Transplant 2007: 26: 681.
30. Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis and risk factors. J Heart Lung Transplant 1998: 17: 1255.
31. Meyers BF, De La Morena M, Sweet SC et al. Primary graft function and other selected complications of lung transplantation: a single centre experience of 983 patients. J Thor Cardiovasc Surg 2006: 129: 1421.
32. Rutherford RM, Fisher AJ, Hilton C et al. Functional status and quality of life in patients surviving 10years after lung transplantation. Am J Transplant 2005: 5: 1099.
33. Verleeden GM, Dupont LJ, Van Raemdonck DE. Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal? Eur Respir J 2005: 24: 221.
34. Chakinala MM, Ritter J, Gage BF et al. Yield of surveillance bronchoscopy for acute rejection and lymphocytic bronchitis/bronchiolitis after lung transplantation. J Heart Lung Transplant 2004: 23: 1396.
35. Khalifah AP, Hachem RR, Chakinala MC et al. Minimal acute rejection after lung transplantation: a risk factor for bronchiolitis obliterans syndrome. Am J Transplant 2005: 5: 2022.
36. Girgis RE, Tu I, Berry GJ et al. Risk factors for the development of obliterative bronchiolitis obliterans after lung transplantation. J Heart Lung Transplant 1996: 15: 1200.
37. Husain AN, Siddiqui MT, Holmes EW et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 1999: 159: 829.
38. Reichenspurner H, Girgis RE, Robbins RC et al. Stanford experience with obliterative bronchitis after lung and heart lung transplantation. Ann Thorac Surg 1996: 62: 1467.
39. De Perrot M, Waddell TK, Shargall Y et al. Impact of donors aged 60years or more on outcome after lung transplantation: results of an 11-year single-center experience. J Thorac Cardiovasc Surg 2007: 133: 525.
40. Hadjiliadis D, Chaparro C, Gutierrez C et al. Impact of lung transplant operation on bronchiolitis obliterans syndrome in patients with chronic obstructive pulmonary disease. Am J Transplant 2006: 6: 183.
41. Chang AC, Chan KM, Lonigro RJ et al. Surgical patient outcomes after the increased use of bilateral lung transplantation. J Thorac Cardiovasc Surg 2007: 133: 532.
42. Speich R, Nicod LP, Aubert JD et al. Ten years of lung transplantation: results of the Swiss Lung Transplant Registry. Swiss Med Wkly 2004: 138: 18.
43. Cassivi SD, Meyers BF, Battafarano RJ et al. Thirteen-year experience in lung transplantation for emphysema. Ann Thorac Surg 2002: 74: 1663.
44. Meyers BF, Lynch J, Trulock EP, Guthrie TJ, Cooper JD, Patterson GA. Lung transplantation: a decade of experience. Ann Thorac Surg 1999: 230: 362.
45. Mason DP, Rajeswaran J, Murthy SC et al. Spirometry after transplantation: how much better are two lungs than one? Ann Thorac Surg 2008: 85: 1193.
46. Pochettino A, Kotloff RM, Rosengard BR et al. Bilateral versus single lung transplantation for chronic obstructive pulmonary disease: intermediate term results. Ann Thorac Surg 2000: 70: 1813.
47. Meyer DM, Bennett LE, Novick RJ, Hosenpud JD. Single vs bilateral, sequential lung transplantation for end stage emphysema: influence of recipient age on survival and secondary endpoints. J Heart Lung Transplant 2001: 20: 935.
48. Meyer DM, Edwards LB, Torres F, Jessen ME, Novick RJ. Impact of recipient age and procedure type on survival after lung transplantation for pulmonary fibrosis. Ann Thorac Surg 2005: 79: 950.
49. Smith PW, Wang H, Parini V et al. Lung transplantation in patients 60years and older: results, complications, and outcomes. Ann Thorac Surg 2006: 82: 1834.
50. Thabut G, Christie JD, Ravaud P, Cartier Y, Brugiere O, Fournier M. Survival after bilateral versus single lung transplantation for patients with chronic obstructive pulmonary disease: a retrospective analysis of registry data. Lancet 2008: 371: 744.
51. Pilcher DV, Snell GI, Scheinkestel CD, Bailay MJ, Williams TJ. High donor age, low donor oxygenation, and high recipient inotrope requirements predict early graft dysfunction in lung transplant recipients. J Heart Lung Transplant 2005: 24: 1814.
52. Sekine Y, Waddell TK, Matte-Martyn A et al. Risk quantification of early outcome after lung transplantation: donor, recipient, operative, and post-transplant parameters. J Heart Lung Transplant 2004: 23: 96.
53. Fischer S, Gohrbrandt B, Struckmeier P et al. Lung transplantation with lungs from donors fifty years of age and older. J Thorac Cardiovasc Surg 2005: 129: 919.
54. Quantz MA, Bennett LE, Meyer DM, Novick RJ. Does human leukocyte antigen mismatching influence the outcome of lung transplantation? An analysis of 3549 lung transplantations. J Heart Lung Transplant 2000: 19: 473.
55. Koegh A, Kaan A, Doran R, Macdonald P, Bryant D, Spratt P. HLA mismatching and outcome in heart, heart-lung and single lung transplantation. J Heart Lung Transplant 1995: 14: 444.
56. Wisser W, Weckerle T, Zlabinger G et al. Influence of human leukocyte antigen matching on long term outcome after lung transplantation. J Heart Lung Transplant 1996: 15: 1209.
57. Schulman LL, Weinberg AD, McGregor C, Galantowicz ME, Suciu-Foca MM, Itescu S. Mismatches at the HLA-DR and HLA-B loci are risk factors for acute rejection after lung transplantation. Am J Respir Crit Care Med 1998: 157: 1833.
58. Sundaresan S, Mohanaklumar T, Smith MA, Trulock EP, Lynch J, Phelan D. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation 1998: 65: 648.
59. Van Den Berg JW, Hepkema BG, Geertsma A et al. Long term outcome of lung transplantation is predicted by the number of HLA-DR-mismatches. Transplantation 2001: 71: 368.
60. Kaczmarek I, Deutsch MA, Rohrer ME et al. HLA-DR matching improves survival after heart transplantation: is it time to change allocation policies? J Heart Lung Transplant 2006: 25: 1057.
61. Weiss ES, Allen JG, Merlo CA, Conte JV, Shah AS. Factors indicative of long-term survival after lung transplantation: a review of 836 10-year survivors. J Heart Lung Transplant 2009: 29: 240.
62. Weiss ES, Allen JG, Merlo CA, Conte JV, Shah AS. Lung allocation score predicts survival in lung transplantation patients with pulmonary fibrosis. Ann Thorac Surg 2009: 88: 1757.
63. Kozower BD, Meyers BF, Smith MA et al. The impact of the lung allocation score on short-term transplantation outcomes: a multicenter study. J Thorac Cardiovasc Surg 2008: 135: 166.